Compare ICU & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICU | SNES |
|---|---|---|
| Founded | 2018 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9M | 14.5M |
| IPO Year | N/A | 2016 |
| Metric | ICU | SNES |
|---|---|---|
| Price | $0.26 | $2.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 37.6K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $881,000.00 | ★ $2,301,000.00 |
| Revenue This Year | $691.85 | $41.52 |
| Revenue Next Year | $64.17 | $77.28 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1195.59 | 39.37 |
| 52 Week Low | $0.22 | $1.30 |
| 52 Week High | $3.07 | $6.24 |
| Indicator | ICU | SNES |
|---|---|---|
| Relative Strength Index (RSI) | 35.81 | 36.08 |
| Support Level | $0.22 | $2.25 |
| Resistance Level | $0.28 | $2.53 |
| Average True Range (ATR) | 0.03 | 0.19 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 25.29 | 11.11 |
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.